MedTrace Logo

Effect of Glucose on Ocular Blood Flow

NCT00350129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2024-03-19

No results posted yet for this study

Summary

The primary objective is to assess the effect of glucose on retinal vascular diameter in otherwise healthy vasospastic subjects compared to non-vasospastic controls.

The secondary objective is to compare the effect of glucose also on choroidal blood flow in otherwise healthy vasospastic subjects with non-vasospastic controls.

Conditions

  • Coronary Vasospasm

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Selim Orgül, MD · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2002-12-31
Primary Completion
2003-02-28
Completion
2003-02-28

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00350129 on ClinicalTrials.gov